Predicting the in Vivo Mechanism of Action for Drug Leads Using NMR Metabolomics
- 18 October 2011
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 7 (1), 166-171
- https://doi.org/10.1021/cb200348m
Abstract
New strategies are needed to circumvent increasing outbreaks of resistant strains of pathogens and to expand the dwindling supply of effective antimicrobials. A common impediment to drug development is the lack of an easy approach to determine the in vivo mechanism of action and efficacy of novel drug leads. Toward this end, we describe an unbiased approach to predict in vivo mechanisms of action from NMR metabolomics data. Mycobacterium smegmatis, a non-pathogenic model organism for Mycobacterium tuberculosis, was treated with 12 known drugs and 3 chemical leads identified from a cell-based assay. NMR analysis of drug-induced changes to the M. smegmatis metabolome resulted in distinct clustering patterns correlating with in vivo drug activity. The clustering of novel chemical leads relative to known drugs provides a mean to identify a protein target or predict in vivo activity.Keywords
This publication has 40 references indexed in Scilit:
- Novel classes of antibiotics or more of the same?British Journal of Pharmacology, 2011
- Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsNature Reviews Microbiology, 2010
- Cytoscape 2.8: new features for data integration and network visualizationBioinformatics, 2010
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugsNucleic Acids Research, 2010
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020Clinical Infectious Diseases, 2010
- Analysis of metabolomic PCA data using tree diagramsAnalytical Biochemistry, 2010
- Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networksBioinformatics, 2010
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- Global trends in emerging infectious diseasesNature, 2008
- Use of NMR Metabolomics To Analyze the Targets of d-Cycloserine in Mycobacteria: Role of d-Alanine RacemaseJournal of Proteome Research, 2007